California Pre-Roll Cannabis Brand Faces Lawsuit For Mislabelled Amounts Of THC In Products

DreamFields and Med for America, the companies behind California pre-roll cannabis brand Jeeter are getting sued.

Last week, a class action lawsuit filed in Los Angeles County Superior Court by Santa Monica, California claims that Jeeter brand pre-rolls contain less THC than advertised.

The move from law firm Dovel & Luner on behalf of plaintiffs Jasper Centeno and Blake Wilson builds on an investigation conducted by WeedWeek, which revealed that the brand's products tested below the THC levels on their label, The Washington Times reported.

The complaint stipulates Baby Jeeter Fire OG Diamond Infused 5-Pack Preroll was listed as having 46% THC on the label. However, independent lab testing conducted by two labs, Anresco and Infinite, revealed that the actual THC content of the product was lower, ranging between 23-27% THC.

In addition, Baby Jeeter Churros Diamond Infused 5-Pack Preroll was listed as having 37% THC on the label, while subsequent testing showed that the actual THC content of the product was between 26% and 29%.

The complaint stated that "consumers reasonably believe that they are receiving a product with the THC content listed on the label," Christin Cho of Dovel & Luner said.

"Consumers are willing to pay more for cannabis products with higher THC content and expect to pay less for cannabis products with lower THC content."

Related News

Photo: Courtesy of succo, mrkukuruznik5 by Pixabay

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsRetail SalesLegalMarketsDreamFieldslawsuits premiumMed for America
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...